
Arachne.ai offers custom computational drug discovery platforms for biotech and pharma companies. Their software engine enables the creation of use-case-specific, data and ML/AI-driven systems for in-silico drug discovery. They address the limitations of generic platforms by providing tailored solutions that integrate with a company's unique data and focus, without requiring data delivery to a third party. Arachne.ai aims to accelerate the drug discovery pipeline by providing tools for data acquisition, integration, and the implementation of predictive algorithms, allowing companies to augment their hypotheses with modern computational methods. The solution is designed for rapid deployment and continuous refinement, offering low-code integration tools, data normalization, secure data handling within the client's infrastructure, and flexible deployment options (cloud, on-premises, hybrid).

Arachne.ai offers custom computational drug discovery platforms for biotech and pharma companies. Their software engine enables the creation of use-case-specific, data and ML/AI-driven systems for in-silico drug discovery. They address the limitations of generic platforms by providing tailored solutions that integrate with a company's unique data and focus, without requiring data delivery to a third party. Arachne.ai aims to accelerate the drug discovery pipeline by providing tools for data acquisition, integration, and the implementation of predictive algorithms, allowing companies to augment their hypotheses with modern computational methods. The solution is designed for rapid deployment and continuous refinement, offering low-code integration tools, data normalization, secure data handling within the client's infrastructure, and flexible deployment options (cloud, on-premises, hybrid).